深部脑刺激术后尿潴留的危险因素:丘脑底核的作用
该回顾性分析纳入2010至2021年在佛罗里达大学因帕金森病(PD)和特发性震颤(ET)接受深部脑刺激(DBS)手术的350例患者共1086次手术,评估术后尿潴留(POUR)的危险因素。结果显示,第一阶段、第二阶段和脉冲发生器更换术后的POUR发生率分别为16.6%、5.2%和0.4%。尿潴留史、男性、首次电极放置或连接、麻醉时间、术前阿片类药物使用和Charlson合并症指数是显著危险因素,而电极位于丘脑底核(STN)对POUR具有保护作用(倾向评分匹配分析:OR 0.2,p=0.010)。
要点
- DBS术后尿潴留发生率在第一阶段为16.6%,第二阶段为5.2%,脉冲发生器更换为0.4%。
- 尿潴留史(OR 9.3)、男性(OR 2.7)、首次电极放置或连接(OR 2.2)是POUR的显著危险因素。
- 电极位于丘脑底核(STN)对POUR具有保护作用(倾向评分匹配分析:OR 0.2,p=0.010)。
核心结论
- 大多数增加DBS术后POUR风险的因素不可改变,但在术前规划中仍应予以考虑。
- 减少阿片类药物使用和缩短麻醉时间可能是可改变的危险因素,需权衡其替代方案。
- 在DBS中靶向STN可能降低POUR发生率,突显了STN靶向DBS在降低PD和ET患者POUR风险方面的潜力。
研究设计与样本
- 回顾性分析2010年至2021年在佛罗里达大学因PD和ET接受DBS手术的患者。
- 手术采用两阶段方案:第一阶段包括钻孔、微电极记录和电极植入;第二阶段包括植入脉冲发生器(IPG)。
- 共纳入350例患者(153例PD,197例ET),共进行1086次DBS手术(电极植入、IPG放置和IPG更换)。
- 数据分析采用单变量和混合线性模型,并使用事后倾向评分匹配确认STN-DBS与POUR的关联。
主要发现
- POUR发生率:第一阶段16.6%(79/477),第二阶段5.2%(19/363),IPG更换0.4%(1/246)。
- 最优混合效应逻辑回归显示,尿潴留史(OR 9.3,p=0.004)、男性(OR 2.7,p=0.011)、首次电极放置或连接(OR 2.2,p=0.014)是POUR的显著危险因素。
- 麻醉时间每增加30分钟(OR 1.5,p<0.0001)、术前阿片类药物使用每增加10吗啡毫克当量(OR 1.4,p=0.032)、Charlson合并症指数每增加一种合并症(OR 1.4,p=0.017)也是显著危险因素。
- 电极位于STN对POUR具有保护作用(倾向评分匹配分析:OR 0.2,p=0.010)。
临床怎么用
- 作者认为,大多数增加POUR风险的因素不可改变,但在术前规划中仍应予以考虑。
- 作者认为,减少阿片类药物使用和缩短麻醉时间可能是可改变的危险因素,需权衡其替代方案。
- 作者认为,在DBS中靶向STN可能降低POUR发生率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Deep brain stimulation (DBS) is a common procedure in neurosurgery used for the treatment of Parkinson's disease (PD) and essential tremor (ET) among other disorders. Lower urinary tract dysfunction is a common complication in PD, and this study aimed to evaluate the risk factors of postoperative urinary retention (POUR) after DBS surgery in patients with PD compared with patients with ET. Understanding the risk factors associated with this complication may help in the development of strategies to minimize its occurrence and improve patient outcomes. METHODS: The study was a retrospective analysis of patients who underwent DBS surgery for PD and ET at the University of Florida between 2010 and 2021. The surgical technique used has been described in previous articles and included a two-stage procedure, with stage 1 involving burr hole placement, microelectrode recording, and electrode implantation and stage 2 involving the placement of an implantable pulse generator (IPG). Data were collected on patient characteristics and surgical details and analyzed using univariate and mixed-linear models. Post hoc propensity score matching was used to confirm the association between subthalamic nucleus (STN)-DBS and POUR. RESULTS: The study included 350 patients (153 with PD and 197 with ET) who underwent 1086 DBS surgeries (lead implantations, IPG placement, and IPG replacements). The POUR rates were 16.6% (79/477), 5.2% (19/363), and 0.4% (1/246) for stage 1, stage 2, and IPG replacement procedures, respectively. Optimal mixed-effects logistic modeling revealed history of urinary retention (OR 9.3, p = 0.004), male sex (OR 2.7, p = 0.011), having an electrode placed or connected for the first time (OR 2.2, p = 0.014), anesthesia time (OR 1.5 for each 30-minute increase, p < 0.0001), preoperative opioid use (OR 1.4 for each additional 10 morphine milligram equivalents, p = 0.032), and Charlson Comorbidity Index (OR 1.4 per comorbidity, p = 0.017) to be significant risk factors for POUR. Having an electrode in the STN was found to be protective of POUR (propensity score-matched analysis: OR 0.2, p = 0.010). CONCLUSIONS: Most risk factors found to increase the risk of POUR in DBS are not modifiable but are still important to consider in preoperative planning. Opioid use reduction and shorter anesthesia time may be modifiable risk factors to weigh against their alternative. Targeting the STN during DBS may result in decreased rates of POUR. This highlights the potential for STN-targeted DBS in reducing POUR risk in PD and ET patients.
引用
- Porche K, Peart R, Silva V, et al. Risk factors for postoperative urinary retention after deep brain stimulation surgery: the role of the subthalamic nucleus. J Neurosurg. 2024. PMID: 38306648. doi:10.3171/2023.11.JNS231668
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。